Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Kidney transplants generally safe for lupus patients

Kidney transplants generally safe for lupus patients

November 02, 2009

Contrary to previous studies, lupus patients who receive kidney transplants rarely develop lupus nephritis

Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. The findings indicate that having lupus should not keep individuals from seeking a kidney transplant if they need one.




Individuals with the autoimmune disease systemic lupus erythematosus (lupus) can experience a number of medical complications, such as lupus nephritis, an inflammatory kidney disorder. Previous studies provide conflicting results about the incidence and severity of lupus nephritis in patients with a history of lupus who have undergone a kidney transplant. Some studies conclude that lupus nephritis is of little consequence while others report that the condition can increase the risk of kidney failure and the risk of death in recipients of a kidney transplant.

Gabriel Contreras, MD, MPH (University of Miami), and his colleagues conducted a thorough evaluation of the frequency of lupus nephritis in kidney transplant recipients and determined the risk this condition has for patients. They mined data from the United Network for Organ Sharing and studied 6850 patients with a history of lupus who received kidney transplants between 1987 and 2006.

The researchers found that lupus nephritis rarely developed in the transplanted kidneys of these lupus patients; it occurred in 2.44% of individuals in the study. When it did occur, lupus nephritis led to a 4-fold increased relative risk of kidney transplant failure; however, the overall risk for the loss of the new organ attributed to lupus developing in the transplanted kidneys was only 7%. During the study period of 19 years, 12.7% of patients died with only 0.4% patients dying in the group with lupus developing in the transplanted kidneys. The investigators also found that African Americans and young women were at higher risk for developing lupus nephritis in their transplanted kidney. Receiving a kidney transplant before or after starting dialysis did not affect one's risk. The type of kidney transplant (deceased vs living donor) also had no effect on a recipient's risk of developing lupus nephritis.

American Society of Nephrology



Related Lupus Nephritis Current Events and Lupus Nephritis News Articles
'Multi-target' immune therapy improves outcomes of severe lupus nephritis
A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of the American Society of Nephrology (JASN).

Ovarian function and fertility preserved in women with severe systemic lupus erythematosus
Ovarian function can be preserved and disease activity controlled in women with severe systemic lupus erythematosus (SLE) when treated with a 6-month course of cyclophosphamide (CYC), a chemotherapy drug, followed by the immunosuppressant mycophenolate mofetil (MMF).

Researchers investigate ways to detect lupus-associated kidney disease
High urinary levels of certain molecules might have the potential to serve as biomarkers for a potentially life-shortening kidney ailment caused by the autoimmune disease lupus, UT Southwestern Medical Center researchers have found.

Treatment of kidney condition requires an individualised
Good patient information is essential for choosing the best treatment for the kidney disease lupus nephritis. Dutch researcher Cecile Grootscholten concludes this following her doctoral research into two methods for treating lupus nephritis.

Clinical trial supports better treatment for lupus nephritis
Treating lupus patients suffering from kidney inflammation with a medicine known as mycophenolate mofetil may be more effective in inducing remission than treating them with the standard regimen of intravenous cyclophosphamide (Cytoxan), a new clinical trial indicates.
More Lupus Nephritis Current Events and Lupus Nephritis News Articles
Lupus Nephritis (Oxford Clinical Nephrology Series)

Lupus Nephritis (Oxford Clinical Nephrology Series)
by Edmund J. Lewis (Editor), Melvin M. Schwartz (Editor), Stephen M. Korbet (Editor)

The presence of severe nephritis is a serious adverse prognostic feature of systemic lupus erythematosus (SLE). The book summarises the remarkable amount of information that has been generated in the quest for relief of patients, mostly young women, who have the unfortunate circumstances of having developed severe lupus nephritis. Lupus nephritis pulls together in one reference source the current knowledge regarding the inherited and immunologic abnormalities which have been identified in SLE with specific reference to the development of renal disease and the way in which these factors may impact upon the chronic care of these patients. This book is also an uptodate resource regarding the diagnosis and management of a broad range of abnormalities which are encountered in the population...

Lupus Nephritis

Lupus Nephritis
Pustulated (Primary Contributor)



The Official Patient's Sourcebook on Lupus Nephritis

The Official Patient's Sourcebook on Lupus Nephritis
by James N. Parker (Author), Icon Health Publications (Author)

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to lupus nephritis (also focal glomerulonephritis; Lupus glomerular disease; lupus glomerulonephritis; Nephritis - lupus), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on...

  CellCept, Rituxan said to show promise for lupus: the two medications are expected to be particularly useful in the treatment of refractory lupus nephritis.(Rheumatology): ... An article from: Internal Medicine News
by Timothy F. Kirn (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on May 1, 2006. The length of the article is 743 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: CellCept, Rituxan said to show promise for lupus: the two medications are expected to be particularly useful in the treatment of refractory lupus nephritis.(Rheumatology)
Author: Timothy F. Kirn
Publication: Internal Medicine News (Magazine/Journal)
Date: May 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 9 Page: 41(1)

Distributed by Thomson...

  Race impacts prognosis, biology of lupus nephritis. (Further SLE Studies Urged).: An article from: Skin & Allergy News
by Elizabeth Mechcatie (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on April 1, 2002. The length of the article is 577 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Race impacts prognosis, biology of lupus nephritis. (Further SLE Studies Urged).
Author: Elizabeth Mechcatie
Publication: Skin & Allergy News (Magazine/Journal)
Date: April 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 4 Page: 28(1)

Distributed by Thomson...

  Lupus Nephritis: Pathophysiology, Diagnosis, and Collaborative Management.: An article from: Nephrology Nursing Journal
by D. Michelle Smith (Author), E. Michelle Fortune-Faulkner (Author), Brenda L. Spurbeck (Author)

This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on April 1, 2000. The length of the article is 8362 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the author: Lupus nephritis (LN) is a complex disease. The pathophysiology involves the glomerulus and mesangium, and its manifestations are exhibited in extensive renal lesions. The World Health Organization (WHO) has developed a classification system to assist clinicians in understanding the severity of renal involvement. The diagnosis of systemic lupus erythematosus (SLE) and LN can be...

  Oral mycophenolate mofetil looks promising for lupus nephritis.(Nephrology): An article from: Internal Medicine News
by Sharon Worcester (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on January 1, 2006. The length of the article is 468 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Oral mycophenolate mofetil looks promising for lupus nephritis.(Nephrology)
Author: Sharon Worcester
Publication: Internal Medicine News (Magazine/Journal)
Date: January 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 1 Page: 18(1)

Distributed by Thomson...

  Childhood onset of lupus presents as more serious illness: nephritis, arthritis, CNS ills.(Clinical Rounds)(Central Nervous System): An article from: Skin & Allergy News
by Bruce Jancin (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on April 1, 2004. The length of the article is 395 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Childhood onset of lupus presents as more serious illness: nephritis, arthritis, CNS ills.(Clinical Rounds)(Central Nervous System)
Author: Bruce Jancin
Publication: Skin & Allergy News (Magazine/Journal)
Date: April 1, 2004
Publisher: International Medical News Group
Volume: 35 Issue: 4 Page: 31(1)

Distributed by Thomson...

  Childhood-onset lupus presents as serious disease; arthritis, nephritis, CNS onset.(Children's Health): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on July 1, 2004. The length of the article is 2470 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Childhood-onset lupus presents as serious disease; arthritis, nephritis, CNS onset.(Children's Health)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: July 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 13 Page: 67(1)

Distributed by Thomson...

  Lupus Nephritis
by Edmund Korbet, Stephen Lewis (Author)



© 2009 BrightSurf.com